Ginsenoside Rg3

Catalog No. A14518

Ginsenoside Rg3影响主动脉内皮依赖性松弛，主动脉松弛。

Product Citations

Nakhjavani M, .et al. Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models, Pharmaceuticals (Basel), 2019, Aug 1;12(3) PMID: 31374984

Technical details

Catalog Num	A14518
M. Wt	785.01
Formula	C42H72O13
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	14197-60-5
Synonyms	20(S)-Ginsenoside-Rg3
SMILES	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C

Solubility *

In vitro	DMSO	97 mg/mL (123.56 mM)
	Water
	Ethanol
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	12.74 mL	63.69 mL	127.39 mL
0.5 mM	2.55 mL	12.74 mL	25.48 mL
1 mM	1.27 mL	6.37 mL	12.74 mL
5 mM	0.25 mL	1.27 mL	2.55 mL

*The above data is based on the productmolecular weight 785.01. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Adooq Bioscience

Ginsenoside Rg3

Product Citations

Technical details

Biological Activity

Solubility *

Preparing Stock Solutions